
Granite Bio Debuts With $100 Million of Capital
BASEL, Switzerland & SAN FRANCISCO--(BUSINESS WIRE)--Granite Bio AG, a clinical-stage immunology company, has emerged from stealth with $100 million in funding. This includes a $30 million Series A led by founding investors Versant Ventures and Novartis Venture Fund, and a $70 million Series B led by Forbion and Sanofi Ventures.
Granite's pipeline features two first-in-class antibodies targeting multiple autoimmune diseases that address large market opportunities.
GRT-001 depletes pro-inflammatory monocytes, key drivers of autoimmunity and inflammation. In non-human primate studies, GRT-001 efficiently and dose-dependently depleted pro-inflammatory monocytes. Treatment was well tolerated and spared tissue-resident macrophages, which are important for tissue homeostasis. GRT-001 is currently in Phase 1a testing in healthy volunteers and is expected to enter a Phase 1b trial in patients with inflammatory bowel disease later this year.
GRT-002 blocks interleukin-3, a key player in autoimmune inflammation and type II inflammation, offering a new approach to treating itch and allergy. The molecule is in preclinical development and is expected to enter clinical trials in 2026.
Both of Granite's lead molecules were developed in collaboration with Versant's Ridgeline Discovery Engine in Basel, Switzerland, and originated from the laboratories of Professor and Scientific Co-Founder Matthias Mack at University of Regensburg.
"Granite is pioneering a new approach to tackling inflammation, autoimmunity, and fibrosis by addressing fundamental disease drivers at their source,' said Patrick Loustau, president and CEO. 'With the support of an exceptional investor syndicate and a world-class team, we are advancing a pipeline of first-in-class therapies with the potential to transform patient outcomes. I look forward to working with the management team to deliver groundbreaking treatments that address the urgent unmet needs in immunology and beyond."
'Despite multiple immunology-based therapeutic approaches currently commercialized, patients with inflammatory disorders continue to experience a lack of symptom control and relapse,' said Nigel Sheail, partner at Versant and Granite board member. 'Granite has the potential to enable a real step change for patients with its innovative programs that target key fundamental disease pathways.'
'I am proud to support Granite as it advances its lead assets using a truly differentiated approach to tackling inflammation at its root,' said Rogier Rooswinkel, Ph.D., General Partner at Forbion and Granite board member. 'With the strength of this investor syndicate and an exceptional leadership team, Granite is well-positioned to drive its pipeline forward and deliver meaningful new therapies for patients.'
Leadership team
Granite is led by an experienced team including:
Patrick Loustau, president and CEO, brings broad and successful experience in building and developing organizations in biotech and pharmaceutical companies. Prior to joining Granite Bio, he was the CBO of Amolyt Pharma until its acquisition by Alexion (AstraZeneca Rare Disease) for up to $1.05B in July 2024. Before Amolyt, he was CEO of Zumbro Discovery Inc. and president of Zafgen Inc. Earlier in his career, he led global organizations at Bristol Myers-Squibb and Novo Nordisk.
Dominik Hartl, M.D., CMO, has extensive background in immunology and fibrosis drug development. He previously served as CMO for Quell Therapeutics, a company specialized in immune-mediated diseases. Before that, he held leadership positions in Immunology Drug Development/Translational Medicine at Novartis (NIBR/Immunology), Roche (pRED/I2O) and Galapagos Pharma. Dominik is a board-certified M.D. and holds an adjunct professorship in Pediatric Immunology at University of Tübingen.
Gijs van den Brink, M.D., Ph.D., CSO, possesses deep academic and industry experience in immunology and IBD. Currently also an Operating Partner at Forbion, he previously served as SVP and Global Head of Immunology, CVM, ID, and Ophthalmology Discovery and Early Development at Roche. Before that, Dr. van den Brink was head of Immunology discovery and early and late-stage clinical development at GlaxoSmithKline plc. Gijs previously was a gastroenterologist and professor of experimental gastroenterology and co-authored over 150 peer-reviewed scientific publications.
Eliot Forster, chairperson of the board, has more than 30 years of extensive biotech experience from both executive and non-executive roles. He was CEO of F-star Therapeutics until its acquisition by inovX Pharma LTD in March 2023, and formerly CEO of Immunocore. Eliot is currently CEO of Levicept LTD, non-executive chair of Tessellate BIO and a director at Immatics.
About Granite Bio
Granite Bio is a biotechnology company developing first-in-class antibodies that target the root causes of a variety of inflammatory, autoimmune and fibrotic conditions. Granite is backed by leading healthcare venture firms including Versant Ventures, Novartis Venture Fund, Forbion and Sanofi Ventures. For more information, please visit www.GRANITEBIO.com.
About Versant Ventures
Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm's emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $5.3 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and R&D expertise that enables a hands-on approach to company building. Since the firm's founding in 1999, more than 95 Versant companies have achieved successful acquisitions or IPOs. For more information, please visit www.versantventures.com.
About NVF
Novartis Venture Fund is a financially driven corporate life science venture fund whose purpose is to foster innovation, drive significant patient benefit and generate superior returns by creating and investing in innovative life science companies at various stages of their development. For more information, go to www.nvfund.com.
About Forbion
Forbion is a leading global venture capital firm with deep expertise in Europe and offices in Naarden, The Netherlands, Munich, Germany and Boston, USA. Forbion invests in innovative biotech companies, managing approximately €5 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. In addition, Forbion leverages its biotech expertise beyond human health to address 'planetary health' challenges through its BioEconomy fund strategy, which invests in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies. Forbion's team consists of over 30 investment professionals that have built an impressive performance track record since the late nineties with 128 investments across 11 funds. Forbion's record of sourcing, building and guiding life sciences companies has resulted in many approved breakthrough therapies and valuable exits. Forbion typically selects impactful investments that will positively affect the health and well-being of people and the planet, as well as meet its financial return objectives. The firm is a signatory to the United Nations Principles for Responsible Investment. Forbion operates a joint venture with BGV, the manager of seed and early-stage funds, especially focused on Benelux and Germany.
About Sanofi Ventures
Sanofi Ventures is the corporate venture capital arm of Sanofi, focused on investing in promising early-stage healthcare companies. The firm supports pioneering innovations in biotechnology, digital health, and life sciences aligning with Sanofi's mission to bring life-changing treatments to patients worldwide. For more information, please visit www.sanofiventures.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
Bank of America Still Sees Upside In a Warner Bros. Discovery Split
Bank of America's securities research team sees the spinoff drama at Warner Bros. Discovery over its linear TV, studios and streaming businesses worth viewing for outsized investor returns. 'We believe the market value for WBD's Studio and DTC (direct-to-consumer) assets standalone could far exceed the market cap of the company today,' BofA Securities analyst Jessica Reif Ehrlich said in a June 2 investor note. A break up of Warner Bros. Discovery since its 2022 merger has long been weighed as a possibility among Wall Street analysts, and Ehrlich sees a potential spinoff of WBD's linear TV assets doing the job of strategically unlocking unrealized shareholder value. More from The Hollywood Reporter Warner Bros. Discovery Credit Rating Cut to Junk Bond Status on Linear TV's Decline John Oliver Slams the "Genius" Who Keeps Changing HBO Max's Name, Admonishes Parent Company Exec for Anticipating His "Hot Take" Behind Warner Bros.' $125 Million Arbitration Win Against Village Roadshow Over 'Matrix Resurrections' A possible scenario would see Warner Bros. studios paired with Max, leaving the Discovery linear cable channels to be carved off and left to operate standalone — a potential model NBCUniversal is doing with Versant. 'Further, as a standalone linear asset, we believe there is an opportunity to consolidate a long tail of linear assets (e.g. Versant) that are currently housed within other media organizations,' Ehrlich argued. While the cable business used to be a cash driver for studios, the TV channels lately have become a drag on earnings, and investors have dinged companies that have been weighed down by channels tied to bundles that have fast fallen out of out of favor with consumers who've spent instead on individual streaming services. NBCU is spinning off most of its cable assets — minus Bravo and including CNBC — into a new company called Versant. No potential split of WBD has been formally announced. But the major studio has already begun to reorganize the company with an eye to a possible spinoff of its legacy TV assets. In Dec. 2024, the studio said it had reworked its corporate structure into a global linear TV division, separate from its streaming and studios division. WBD added it had begun the early steps leading toward the new corporate reorganization, with a completion set for mid-2025. Ehrlich said the new corporate structure was designed to 'enhance strategic flexibility and create potential opportunities to unlock shareholder value', as WBD operates in two divisions. The Wall Street analyst also addressed WBD recently being downgraded to BB+, or junk bond status, for 2025 and 2026 by S&P Global over linear TV weakness as the Hollywood studio continues to pivot to the streaming space. 'Ironically, we view this as a positive development,' Ehrlich wrote as the downgrade potentially contributes to WBD's balance sheet flexibility. Gunnar Wiedenfels, CFO of WBD, on May 15 during an investors conference appearance put no timing on possible 'strategic action' at the company to better reveal the underlying value of studio assets. 'I can't give a specific timeline, and there is no specific timeline. But we definitely share the view that our current share price is not reflecting the underlying the value of our company,' he said. The BofA Global Research analyst maintained a buy rating and a price target of $14.00 for shares in WBD. The studio's stock was trading up 5 cents to $9.98 in early afternoon trading on Monday. Best of The Hollywood Reporter How the Warner Brothers Got Their Film Business Started Meet the World Builders: Hollywood's Top Physical Production Executives of 2023 Men in Blazers, Hollywood's Favorite Soccer Podcast, Aims for a Global Empire
Yahoo
4 days ago
- Yahoo
Ramp Metals Completes Spring Drill Program and Announces Additional Mineralization at Rush Target
Vancouver, British Columbia--(Newsfile Corp. - June 6, 2025) - Ramp Metals Inc. (TSXV: RAMP) ("Ramp Metals" or the "Company") is pleased to announce that the Company has completed its spring drill program on the Rottenstone SW property. The Company completed 20 drill holes for a total of 4,942 metres. Airborne geophysics using the Xcite HTDEM system, with 100-metre line spacing to provide high-resolution data for target refinement, was also completed over the entire Rottenstone SW property package. Highlights 20 drill holes totalling 4,942 metres were completed, with every metre being sent for assays 8 holes totalling 2,116 metres were drilled at the Ranger target where 73.55 g/t Au over 7.5m was previously discovered in Ranger-001 drill hole 10 holes were drilled at the Rush target with additional VMS style mineralization intersected in 150m step-out 3 holes for a total of 968 metres were drilled at the Rogue target Airborne magnetic and TDEM geophysical survey was completed over the remainder of the Rottenstone SW property using the Xcite HTDEM system "It's exciting to announce that we have completed our spring drill program at the Rottenstone SW property," said Jordan Black, CEO of Ramp Metals. "The program was a huge success completing more holes than originally planned, encountering the quartz diorite package at Ranger and potentially making a new discovery at the Rush target." Figure 1: Rottenstone SW - 2025 Drill Collar Locations To view an enhanced version of this graphic, please visit: Ranger A total of 8 drill holes were completed at the Ranger target (Figure 2). Seven drill holes were completed around the Ranger-001 discovery hole. All 7 holes intersected significant widths of the quartz-diorite package which hosted the previously announced high grade gold intercept of 73.55 g/t Au over 7.5m as reported in the June 17, 2024 News Release. The remaining hole was designed to test a conductor located approximately 1.5km to the north-east, which was identified in the recently completed airborne geophysics (Figure 3). Altered tonalite and metasediments with Pyrrhotite mineralization were encountered. The hole was ended early at 200m due to time constraints. Management believes that further testing is warranted on the eastern Ranger anomalies. Figure 2: Ranger - 2025 Drill Hole Collars and Drill Traces To view an enhanced version of this graphic, please visit: Figure 3: Ranger Drill Collars and Drill Hole Traces with EM To view an enhanced version of this graphic, please visit: Rush A total of 10 holes were drilled at the newly identified Rush VMS target (Figure 4). Semi-massive to massive sulphide mineralization was noted in 5 drill holes, with the presence chalcopyrite and sphalerite being confirmed with a Thermo Scientific™ Niton™ XL5 Plus handheld XRF analyzer. Minor amounts of galena were also noted. Rush-010 intersected net textured to semi-massive sulphide over approximately 4.16m from 21.4m-25.56m (Photo 1). Disseminated to blebby sulphides were also intersected to a depth of approximately 47m (Photo 2). This intersection represents a 150m step-out to the north-east from the initial discovery area where Rush 001, 002, 003, and 009 were drilled. Rush-010 was designed to intercept the outcrop found during the October 2024 field program at depth. Surface rock samples at this outcrop returned values of up to 1.61% copper, 0.79 g/t gold, and 113 g/t silver, as was previously reported in the January 20, 2025 News Release. Figure 4: Rush - 2025 Drill Collars and Drill Hole Traces To view an enhanced version of this graphic, please visit: Photo 1: Rush-010 Boxes 5 & 6 - Net textured to semi-massive mineralization from 21.4-25.56m To view an enhanced version of this graphic, please visit: Photo 2: Rush-010 Boxes 9 & 10 - Disseminated to blebby chalcopyrite mineralization throughout To view an enhanced version of this graphic, please visit: Rogue A total of 3 holes were drilled at the Rogue target (Figure 5). These holes were designed to test structural and conductive targets in an area where soil samples of up to 530.7ppb Au were previously reported in the January 20, 2025 News Release. Pyrrhotite and pyrite mineralization was encountered in two of the three holes (Rogue 005 & 006). Rogue 005 & 006 also encountered sections of potassic and hematite altered diorite and fractures (Photos 3 & 4). During the program, drilling at Rogue was limited due to the overall total number of holes covered by the most recent permit package. The Company believes that the Rogue target warrants further exploration to explain the source of the highly anomalous gold in soils. Figure 5: Rogue - 2025 Drill Collar Locations and Drill Hole Traces To view an enhanced version of this graphic, please visit: Photo 3: Rogue-005 Boxes 25 & 26 - Potassic alteration of diorite and hematite altered fractures To view an enhanced version of this graphic, please visit: Photo 4: Rogue-006 Boxes 61 & 62 - Coarse-grained diorite with potassic alteration To view an enhanced version of this graphic, please visit: Geophysics The Company has completed a magnetic and TDEM survey over the remainder of the Rottenstone SW property using the Xcite HTDEM system. A total of 3,342 line-km was flown at 100m spacing to provide a high-resolution Mag and EM dataset over the entire property. Data is currently being processed, and the Company will provide a further update once the data processing is completed. Next Steps With the present forest fire situation in northern Saskatchewan, the Company felt it prudent to relocate all drill core to a facility in the Prince Albert area to safely complete processing and preparation for assays. The first shipment of samples has been delivered and is being analyzed at Bureau Veritas Commodities Canada Ltd. ("BV") in Vancouver, BC. All remaining core has been fully logged and is currently being cut and sorted for shipping. The Company plans to return to the Rottenstone SW property for further mapping and sampling once the data from the airborne geophysics and drill programs have been analyzed, and the fire risk has subsided. A ground geophysics program is also planned for the summer to help better define the conductive targets on the property. An amendment to the current permits requesting up to 30,000m of additional drilling and a 30-person camp is being prepared and is expected to be submitted shortly. Acknowledgements Ramp Metals would like to thank the Lac La Ronge Indian Band and all land users for their continued support and working closely with the Company through the permitting process. The Company would also like to thank all the contractors who made the 2025 winter/spring drill program a success. Drilling: Flamingo Drilling through Athabasca Catering Limited Partnerships Geology and Geophysics: Axiom Exploration Group Ltd. (Mikaela Miller, Craig Cubbon, Logan Anaka) Accommodations: Thompson's Resort - Adventure Destinations Flight Services: Heli-Recon Aerial Support Services Inc. and Osprey Wings Ltd. Fuel Services: Millsap Fuel Distributors Ltd. Local Contractors: Cecil Mcleod, Alex Mcleod, Bradley McKenzie, Ethan Ballantyne, Joey McKenzie, Chris Roberts, Joe Stanley, Jimmy McKenzie, Riley Provencher Quality Assurance/Quality Control Uncut whole NQ drill core was analyzed by a Thermo Scientific™ Niton™ XL5 Plus handheld XRF, operated by Ramp Metals staff on site. The Portable X-Ray Fluorescence ("pXRF") data is exploratory in nature and is used predominantly as an internal workflow to assist in target prioritization and mineral identification through an early phase of exploration investigation. pXRF data is not provided as it is not an indicator of representative geochemistry of the entire rock mass and therefore should only be viewed as an initial screening prior to laboratory assays. Drill core is currently being sampled and cut by diamond saw. Samples will be shipped as they are processed for laboratory analysis at BV, an internationally recognized and ISO 17025:2017 accredited analytical services provider, at its Vancouver, BC laboratory. Drill core samples are marked in maximum intervals of up to 1.5m and cut in half using a diamond saw with half sent for assay and the other half saved for reference. Samples are then bagged and zip-tied, with 15 bagged samples placed into sealed rice bags and then 20 rice bags placed in mega bags for transport to BV. Sample QA/QC procedures were applied by inserting a regular and systematic schedule of standards, blanks and duplicates into the sample stream. Control samples consisting of certified reference samples and blank samples were systematically inserted into the sample stream and analyzed as part of the Company's QA/QC protocol at a rate of 1:15 or better in addition to BV's internal quality assurance programs. Rock samples are prepared using the PRP70-250 package, where samples are weighed, dried, and crushed to greater than 70% passing a 2mm sieve, then pulverized to greater than 85% passing 75 microns. Samples are analyzed in accordance with BV's MA300 and FA330 packages, for both multi-element ICP analysis (0.25 g, multi-acid and ICP-ES analysis) and gold analysis by fire assay (30g fire assay with AAS finish). Gold returning >10ppm is automatically analyzed by gravimetric method in accordance with BV's standard of practice. Qualified Person Brett Williams, VP Operations and Senior Geologist for Ramp Metals, and a "qualified person" under National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the technical content in this news release. About Ramp Metals Inc. Ramp Metals is a grassroots exploration company with a focus on a potential new Saskatchewan gold district. The Company currently has a new high-grade gold discovery of 73.55 g/t Au over 7.5m at its flagship Rottenstone SW property. The Rottenstone SW property comprises 32,715 hectares and is situated in the Rottenstone Domain. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. FORWARD-LOOKING STATEMENTS This news release contains "forward-looking statements" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding the Company's exploration activities. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: requirements for additional capital; future prices of minerals; changes in general economic conditions; changes in the financial markets and in the demand and market price for commodities; other risks of the mining industry; the inability to obtain any necessary governmental and regulatory approvals; changes in laws, regulations and policies affecting mining operations; hedging practices; and currency fluctuations. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. For further information, please contact: Ramp Metals Inc. Jordan BlackChief Executive Officerjordaneblack@ Prit SinghDirector905 510 7636 To view the source version of this press release, please visit


New York Post
4 days ago
- New York Post
An ‘international gold rush' could be on its way — and it's because of a ‘significant' discovery in Finland
A single drill hole in Finland has unearthed a significant gold deposit, sending shockwaves through the global markets in what could likely be a new international gold rush. The significant discovery was confirmed to be found in bedrock samples taken from the site in February along the Karelian Gold Line in Ukkolanvaara, according to mining and exploration company Endomines. The initial drill hole, named UKKO-001, hit three major gold-rich sections and has exceeded expectations, the company's CEo, Kari Vyhtinen, said. 'An impressive result was achieved with the very first drill hole,' he notes. 'The result confirms the great gold potential of the Ukko-deposit in Ukkolanvaara. Three such high-grade gold zones in the same drill hole is something we have never seen before in exploration.' Vyhtinen said their plan was to conduct only a three-to four-week research campaign in the area, but the company has now decided to continue the investigations indefinitely. 'The iron deposit in Ukkolanvaara is very extensive,' he adds. 'Additionally, observations of visible gold in several drill holes indicate that gold is present over a wider area in connection with the iron deposit.' The significant discovery was confirmed to be found in bedrock samples taken from the site in February along the Karelian Gold Line in Ukkolanvaara. Roman Bodnarchuk – The initial drill hole, named UKKO-001, hit three major gold-rich sections and has exceeded expectations. Dmitry Naumov – Vyhtinen believes the gold discovery will prove to be 'significant.' The company's findings show various samples of gold ranging upwards of nearly 10 grams per metric ton. To date, 12 holes have been drilled, with more results pending.